HLA-A and colorectal carcinoma: Since APC-F2-1472* and APC-F3-1512* were found in approximately 5.0% and 1.5% of CRC patients, respectively, frameshift neoantigens presented on HLA-A*24:02 from these clusters were calculated to be applicable to approximately 3.0% and 0.9% of Japanese CRC patients, based on the assumption of the HLA-A*24:02 allelic frequency of about 61% in the Japanese population (30).